These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8457292)

  • 1. Direct growth stimulation of normal human epithelial cells by mutant p53.
    Wyllie FS; Lemoine NR; Barton CM; Dawson T; Bond J; Wynford-Thomas D
    Mol Carcinog; 1993; 7(2):83-8. PubMed ID: 8457292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stepwise transformation of primary thyroid epithelial cells by a mutant Ha-ras oncogene: an in vitro model of tumor progression.
    Burns JS; Blaydes JP; Wright PA; Lemoine L; Bond JA; Williams ED; Wynford-Thomas D
    Mol Carcinog; 1992; 6(2):129-39. PubMed ID: 1388684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Partial transformation of human thyroid epithelial cells by mutant Ha-ras oncogene.
    Lemoine NR; Staddon S; Bond J; Wyllie FS; Shaw JJ; Wynford-Thomas D
    Oncogene; 1990 Dec; 5(12):1833-7. PubMed ID: 1704496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evasion of p53-mediated growth control occurs by three alternative mechanisms in transformed thyroid epithelial cells.
    Wyllie FS; Haughton MF; Blaydes JP; Schlumberger M; Wynford-Thomas D
    Oncogene; 1995 Jan; 10(1):49-59. PubMed ID: 7529918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immortalization of human mammary epithelial cells transfected with mutant p53 (273his).
    Gollahon LS; Shay JW
    Oncogene; 1996 Feb; 12(4):715-25. PubMed ID: 8632893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initiation of human astrocytoma by clonal evolution of cells with progressive loss of p53 functions in a patient with a 283H TP53 germ-line mutation: evidence for a precursor lesion.
    Fulci G; Ishii N; Maurici D; Gernert KM; Hainaut P; Kaur B; Van Meir EG
    Cancer Res; 2002 May; 62(10):2897-905. PubMed ID: 12019170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction between p53 and TGF beta 1 in control of epithelial cell proliferation.
    Blaydes JP; Schlumberger M; Wynford-Thomas D; Wyllie FS
    Oncogene; 1995 Jan; 10(2):307-17. PubMed ID: 7838530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro reconstruction of tumour initiation in a human epithelium.
    Bond JA; Wyllie FS; Rowson J; Radulescu A; Wynford-Thomas D
    Oncogene; 1994 Jan; 9(1):281-90. PubMed ID: 8302590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutant p53 expression in fallopian tube epithelium drives cell migration.
    Quartuccio SM; Karthikeyan S; Eddie SL; Lantvit DD; Ó hAinmhire E; Modi DA; Wei JJ; Burdette JE
    Int J Cancer; 2015 Oct; 137(7):1528-38. PubMed ID: 25810107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlated abnormalities of transforming growth factor-beta 1 response and p53 expression in thyroid epithelial cell transformation.
    Wyllie FS; Dawson T; Bond JA; Goretzki P; Game S; Prime S; Wynford-Thomas D
    Mol Cell Endocrinol; 1991 Apr; 76(1-3):13-21. PubMed ID: 1820969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Escape from senescence in human diploid fibroblasts induced directly by mutant p53.
    Bond JA; Wyllie FS; Wynford-Thomas D
    Oncogene; 1994 Jul; 9(7):1885-9. PubMed ID: 8208534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roles of the functional loss of p53 and other genes in astrocytoma tumorigenesis and progression.
    Nozaki M; Tada M; Kobayashi H; Zhang CL; Sawamura Y; Abe H; Ishii N; Van Meir EG
    Neuro Oncol; 1999 Apr; 1(2):124-37. PubMed ID: 11550308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New p53-based anti-cancer therapeutic strategies.
    Wiman KG
    Med Oncol; 1998 Dec; 15(4):222-8. PubMed ID: 9951684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of retrovirally driven therapeutic genes by mutant TP53 in anaplastic thyroid carcinoma.
    Barzon L; Gnatta E; Castagliuolo I; Trevisan M; Moretti F; Pontecorvi A; Boscaro M; Palù G
    Cancer Gene Ther; 2005 Apr; 12(4):381-8. PubMed ID: 15650765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutant p53-induced immortalization of primary human mammary epithelial cells.
    Gao Q; Hauser SH; Liu XL; Wazer DE; Madoc-Jones H; Band V
    Cancer Res; 1996 Jul; 56(13):3129-33. PubMed ID: 8674072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-derived p53 mutants induce oncogenesis by transactivating growth-promoting genes.
    Scian MJ; Stagliano KE; Deb D; Ellis MA; Carchman EH; Das A; Valerie K; Deb SP; Deb S
    Oncogene; 2004 May; 23(25):4430-43. PubMed ID: 15077194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.
    Ruggeri BA; Huang L; Berger D; Chang H; Klein-Szanto AJ; Goodrow T; Wood M; Obara T; Heath CW; Lynch H
    Cancer; 1997 Feb; 79(4):700-16. PubMed ID: 9024708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene therapy for primary and metastatic pancreatic cancer with intraperitoneal retroviral vector bearing the wild-type p53 gene.
    Hwang RF; Gordon EM; Anderson WF; Parekh D
    Surgery; 1998 Aug; 124(2):143-50; discussion 150-1. PubMed ID: 9706132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transfected mutant p53 gene increases X-ray-induced cell killing and mutation in human fibroblasts immortalized with 4-nitroquinoline 1-oxide but does not induce neoplastic transformation of the cells.
    Kawashima K; Mihara K; Usuki H; Shimizu N; Namba M
    Int J Cancer; 1995 Mar; 61(1):76-9. PubMed ID: 7705936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Significance of aberrant p53 protein in head-neck tumors and its effect on proliferation and differentiation].
    Homann N; Andl T; Nees M; Schuhmann A; Herold-Mende C; Bosch FX
    HNO; 1993 May; 41(5):254-60. PubMed ID: 8392993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.